Your browser doesn't support javascript.
loading
Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies.
Hellyer, Jessica A; Gubens, Matthew A; Cunanan, Kristen M; Padda, Sukhmani K; Burns, Matthew; Spittler, A John; Riess, Jonathan W; San Pedro-Salcedo, Melanie; Ramchandran, Kavitha J; Neal, Joel W; Wakelee, Heather A; Loehrer, Patrick J.
Afiliação
  • Hellyer JA; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA.
  • Gubens MA; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA; University of California San Francisco, 1450 3rdSt, San Francisco, CA, USA.
  • Cunanan KM; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA.
  • Padda SK; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA.
  • Burns M; Indiana University Melvin and Bren Simon Cancer Center, 535 Barnhill Dr. Indianapolis, IN, USA.
  • Spittler AJ; Indiana University Melvin and Bren Simon Cancer Center, 535 Barnhill Dr. Indianapolis, IN, USA.
  • Riess JW; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA; UC Davis Comprehensive Cancer Center, 2279 45thSt, Sacramento, CA, USA.
  • San Pedro-Salcedo M; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA.
  • Ramchandran KJ; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA.
  • Neal JW; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA.
  • Wakelee HA; Stanford University School of Medicine and Stanford Cancer Institute, 875 Blake Wilbur Driver, Stanford, CA, USA. Electronic address: hwakelee@stanford.edu.
  • Loehrer PJ; Indiana University Melvin and Bren Simon Cancer Center, 535 Barnhill Dr. Indianapolis, IN, USA.
Lung Cancer ; 137: 71-75, 2019 11.
Article em En | MEDLINE | ID: mdl-31557562
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Terapia de Salvação / Antraciclinas / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Terapia de Salvação / Antraciclinas / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article